These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1474 related items for PubMed ID: 10579212
1. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats. Pollack AE, Yates TM. Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212 [Abstract] [Full Text] [Related]
8. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT, White FJ. Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [Abstract] [Full Text] [Related]
10. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Paul ML, Graybiel AM, David JC, Robertson HA. J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113 [Abstract] [Full Text] [Related]
12. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Bronstein DM, Ye H, Pennypacker KR, Hudson PM, Hong JS. Brain Res Mol Brain Res; 1994 May; 23(3):191-203. PubMed ID: 7914658 [Abstract] [Full Text] [Related]
13. Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats. Drake JD, Kibuuka LN, Dimitrov KD, Pollack AE. Pharmacol Biochem Behav; 2013 Apr; 105():26-33. PubMed ID: 23369985 [Abstract] [Full Text] [Related]
14. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study. Hassani OK, Féger J. Neuroscience; 1999 Apr; 92(2):533-43. PubMed ID: 10408602 [Abstract] [Full Text] [Related]
15. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. LaHoste GJ, Yu J, Marshall JF. Proc Natl Acad Sci U S A; 1993 Aug 15; 90(16):7451-5. PubMed ID: 8102797 [Abstract] [Full Text] [Related]
16. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats. Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP. Neurotox Res; 2003 Aug 15; 5(5):329-38. PubMed ID: 14715452 [Abstract] [Full Text] [Related]
17. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. LaHoste GJ, Marshall JF. Synapse; 1992 Sep 15; 12(1):14-26. PubMed ID: 1357762 [Abstract] [Full Text] [Related]
19. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. Puschban Z, Scherfler C, Granata R, Laboyrie P, Quinn NP, Jenner P, Poewe W, Wenning GK. Neuroscience; 2000 Dec 28; 95(2):377-88. PubMed ID: 10658617 [Abstract] [Full Text] [Related]
20. NMDA glutamate receptor stimulation is required for the expression of D2 dopamine mediated responses in apomorphine primed 6-hydroxydopamine lesioned rats. Pollack AE, Haisley EC. Brain Res; 2001 Apr 06; 897(1-2):213-6. PubMed ID: 11282380 [Abstract] [Full Text] [Related] Page: [Next] [New Search]